COVID-19 and Clinical Trials

COVID-19 has caused some clinical studies to delay patient enrollment. Yet, for studies currently underway, it’s not as easy as hitting the pause button.
 

Patients need access to treatments, and sites, sponsors and CROs have been moving at warp speed to determine how to recon gure protocols to deliver care amidst these challenging conditions.
 

We’ve seen amazing examples of how the industry has rallied, continuing to deliver on needed medical innovation.
 

In this webinar we discuss:

• A synopsis of recent FDA & EMA guidance
• A recap of our brand new site survey.  Hear what more than 1,800 sites said they are doing to weather the storm, and challenges that remain.
• An overview of Greenphire's entire suite of payment and travel solutions designed to increase transparency, reduce administrative burdens and introduce patient convenience, including new enhancements that provide even stronger support for sponsors and CROs, sites and patients amidst